Parmax Pharma Ltd

As per regulation 30 and 33 of SEBI (LODR) Regulations 2015 the board of directors at its meeting held on 14th November 2024 inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September 2024 along with the Limited Review Report provided by B A Shah S R Mehta statutory Auditor of the company.